ADIZEM

Brand name authorized in: Ireland United Kingdom

Active ingredients

The drug ADIZEM contains one active pharmaceutical ingredient (API):

1 Diltiazem
UNII EE92BBP03H - DILTIAZEM

Diltiazem is a calcium antagonist. It restricts the slow channel entry of calcium into the cell and so reduces the liberation of calcium from stores in the sarcoplasmic reticulum. This results in a reduction of the amount of available intracellular calcium reducing myocardial oxygen consumption.

Read about Diltiazem

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
Diltiazem
C Cardiovascular system → C08 Calcium channel blockers → C08D Selective calcium channel blockers with direct cardiac effects → C08DB Benzothiazepine derivatives
Discover more medicines within C08DB01

Medication package inserts

Below package inserts are available for further reading:

Title
Type
Country
Summary of product characteristics (SPC)
UK

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
GB
Medicines & Healthcare Products Regulatory Agency
Identifier(s): 198719, 198721, 28862, 28864, 28866, 28868, 28871, 28875, 29379, 29381, 299545, 299549, 299551, 299555, 299557, 299559, 299561, 299626, 381152, 381154, 381156, 381158, 381160, 381162
IE
Health Products Regulatory Authority
Identifier(s): 56839, 56847, 56855, 60402, 60424, 60436, 60487